Vertex Pharmaceuticals Inc (VRTX)
445.21
+4.57
(+1.04%)
USD |
NASDAQ |
May 17, 16:00
445.28
+0.08
(+0.02%)
After-Hours: 20:00
Vertex Pharmaceuticals 30-Day Average Daily Volume: 1.081M for May 17, 2024
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| May 17, 2024 | 1.081M |
| May 16, 2024 | 1.059M |
| May 15, 2024 | 1.050M |
| May 14, 2024 | 1.039M |
| May 13, 2024 | 1.041M |
| May 10, 2024 | 1.035M |
| May 09, 2024 | 1.036M |
| May 08, 2024 | 1.043M |
| May 07, 2024 | 1.020M |
| May 06, 2024 | 990813.4 |
| May 03, 2024 | 969417.5 |
| May 02, 2024 | 963791.9 |
| May 01, 2024 | 955297.8 |
| April 30, 2024 | 942079.5 |
| April 29, 2024 | 915363.9 |
| April 26, 2024 | 958735.0 |
| April 25, 2024 | 970364.7 |
| April 24, 2024 | 969598.4 |
| April 23, 2024 | 972349.2 |
| April 22, 2024 | 978786.7 |
| April 19, 2024 | 959488.6 |
| April 18, 2024 | 945528.2 |
| April 17, 2024 | 954642.3 |
| April 16, 2024 | 962744.0 |
| April 15, 2024 | 976943.9 |
| Date | Value |
|---|---|
| April 12, 2024 | 967896.3 |
| April 11, 2024 | 989521.8 |
| April 10, 2024 | 980396.0 |
| April 09, 2024 | 976752.1 |
| April 08, 2024 | 978780.6 |
| April 05, 2024 | 978711.4 |
| April 04, 2024 | 991915.8 |
| April 03, 2024 | 990561.8 |
| April 02, 2024 | 1.001M |
| April 01, 2024 | 1.009M |
| March 28, 2024 | 1.032M |
| March 27, 2024 | 1.034M |
| March 26, 2024 | 1.042M |
| March 25, 2024 | 1.056M |
| March 22, 2024 | 1.071M |
| March 21, 2024 | 1.090M |
| March 20, 2024 | 1.127M |
| March 19, 2024 | 1.250M |
| March 18, 2024 | 1.286M |
| March 15, 2024 | 1.327M |
| March 14, 2024 | 1.313M |
| March 13, 2024 | 1.371M |
| March 12, 2024 | 1.456M |
| March 11, 2024 | 1.460M |
| March 08, 2024 | 1.450M |
30-Day Average Daily Volume Range, Past 5 Years
814832.4
Minimum
Sep 19 2023
2.927M
Maximum
Jul 20 2021
1.564M
Average
1.467M
Median
Feb 13 2023
30-Day Average Daily Volume Benchmarks
| Amgen Inc | 2.650M |
| Eli Lilly and Co | 2.626M |
| Regeneron Pharmaceuticals Inc | 470582.3 |
| Alpine Immune Sciences Inc | 3.600M |
| Editas Medicine Inc | 1.841M |